Viral Vectors Market to Grow by $ 385.78 mn in 2020, Asklepios BioPharmaceutical Inc. and Batavia Biosciences BV Emerge as Key Contributors to Growth | Industry Analysis, Market Trends, Opportunities and Forecast 2024 | Technavio
Technavio has been monitoring the viral vectors market and it is poised to grow by $ 385.78 mn during 2020-2024, progressing at a CAGR of almost 15% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
The COVID-19 pandemic continues to transform the growth of various industries, however, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. COVID-19 will have a high impact on the viral vectors market. The market growth in 2020 is likely to increase compared to the market growth in 2019.
Frequently Asked Questions:
What are the major trends in the market?
Emergence of novel technologies to manufacture viral vectors is a major trend driving the growth of the market.
At what rate is the market projected to grow?
The market will accelerate at a CAGR of almost 15% and the incremental growth of the market is anticipated to be $ 385.78 mn.
Who are the top players in the market?
Asklepios BioPharmaceutical Inc., Batavia Biosciences BV, Cobra Biologics Ltd., Creative Biogene, FinVector Oy, Lonza Group Ltd., Merck KGaA, Novasep Holding SAS, Oxford Biomedica Plc, and Thermo Fisher Scientific Inc., are some of the major market participants.
What is the key market driver?
The rising prevalence of chronic diseases is one of the major factors driving the market.
How big is the North America market?
The North America region will contribute to 60% of the market share.
Microarray Biochips Market by Application and Geography - Forecast and Analysis 2020-2024 - The microarray biochips market size has the potential to grow by USD 10.22 billion during 2020-2024, and the market's growth momentum will accelerate at a CAGR of 19.84%. To get extensive research insights: Click and get FREE sample report in minutes
Proteomics Market by Product, Application, and Geography - Forecast and Analysis 2020-2024 - The proteomics market size has the potential to grow by USD 15.82 billion during 2020-2024, and the market's growth momentum will accelerate at a CAGR of 13.73%. To get extensive research insights: Click and get FREE sample report in minutes
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The market is concentrated, and the degree of concentration will accelerate during the forecast period. Asklepios BioPharmaceutical Inc., Batavia Biosciences BV, Cobra Biologics Ltd., Creative Biogene, FinVector Oy, Lonza Group Ltd., Merck KGaA, Novasep Holding SAS, Oxford Biomedica Plc, and Thermo Fisher Scientific Inc. are some of the major market participants. The rising prevalence of chronic diseases will offer immense growth opportunities. In a bid to help players strengthen their market foothold, this viral vectors market forecast report provides a detailed analysis of the leading market vendors. The report also empowers industry honchos with information on the competitive landscape and insights into the different product offerings offered by various companies.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The viral vectors market report covers the following areas:
Viral Vectors Market Size
Viral Vectors Market Trends
Viral Vectors Market Industry Analysis
This study identifies the emergence of novel technologies to manufacture viral vectors as one of the prime reasons driving the viral vectors market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist viral vectors market growth during the next five years
Estimation of the viral vectors market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the viral vectors market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of viral vectors market vendors
Table of Contents:
Executive Summary
Market Landscape
Market ecosystem
Market characteristics
Value chain analysis
Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019?2024
Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by Application
Market segments
Comparison by Application
Gene therapy - Market size and forecast 2019-2024
Vaccines - Market size and forecast 2019-2024
Market opportunity by Application
Customer Landscape
Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends
Vendor Landscape
Vendor landscape
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
Asklepios BioPharmaceutical Inc.
Batavia Biosciences BV
Cobra Biologics Ltd.
Creative Biogene
FinVector
Lonza Group Ltd.
Merck KGaA
Novasep Holding SAS
Oxford Biomedica Plc
Thermo Fisher Scientific Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Sorcero, the leading provider of advanced AI solutions purpose-built for life sciences, today announced the release of Scientific Sentiment, enabling Life Sciences teams, for the first time, to quantify product perception across KOLs and the market...
Uwill, the leading mental health and wellness solution for students, proudly announces its inclusion on the prestigious EdTech Digest Awards 'Cool Tool' list for 'Best Higher Education Solution'. This acknowledgement highlights Uwill's commitment to...
Sports nutrition and lifestyle brand Bucked Up launched its Babe by Bucked Up line last October with a desire to create supplements made by women, for women. With its official launch now six months underway, Babe has become a huge sensation and...
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...